Clin2
NCT07242443Likely a fitNot yet recruiting

Twice-daily vs three-times-daily medication for H. pylori infection

HELICOBACTER PYLORI INFECTIONS

Treatments studied

Part of Digestive system clinical trials.

This study compares two ways of taking the same combination of medicines (tegoprazan and amoxicillin) to treat an H. pylori stomach infection. One group takes the medicines twice daily, the other three times daily, to see which schedule works better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
240 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have a confirmed H. pylori (stomach infection) diagnosis.
  • You are not allergic to amoxicillin or any penicillin-type antibiotics.
  • You have not taken antibiotics, acid reducers, or bismuth products in the past 4 weeks.
  • You have no severe liver or kidney problems, and you are not pregnant or breastfeeding.
  • You are able to complete follow-up tests 4 to 8 weeks after treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07275827Recruiting· Phase 3
Testing 3 treatments for H. pylori infection

This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.

Shibīn al Kawm
NCT07750938Not yet recruiting· Phase 4
Better acid control for first-time H. pylori treatment

This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.

NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.

NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.